Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Santen Ventures
AddedMar 19, 2024
UpdatedJun 28, 2026
Santen Ventures

Santen Ventures

Public

Leading eye care center and pharmaceutical company

HQ
Emeryville, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Santen Ventures, based in Emeryville, California, is a wholly-owned subsidiary of Santen Holdings. The company is dedicated to investing in promising seed-stage firms that are developing innovative technologies, particularly in the field of eye care and pharmaceuticals. Their core mission is to advance eye health and vision by supporting groundbreaking innovations that can lead to new treatments and therapies. Santen Ventures focuses on identifying and nurturing early-stage companies that have the potential to make significant contributions to the healthcare market.

Notable affiliated individuals include executives from Santen Holdings, who bring extensive experience in the pharmaceutical industry. Key investors are primarily from Santen Holdings, ensuring strong financial backing and strategic guidance. Among their achievements, Santen Ventures has successfully identified and invested in several pioneering startups that have gone on to develop impactful eye care solutions. The overall impact of Santen Ventures is seen in their contribution to advancing medical technology and improving patient outcomes in the field of ophthalmology.

Santen Ventures - Similar Companies

Takeda logo

Takeda

takeda.com

Secure Ventures logo

Secure Ventures

secureventures.io

Sorrento Ventures logo

Sorrento Ventures

P74 Ventures logo

P74 Ventures

Ten Ventures logo

Ten Ventures

Senator Ventures logo

Senator Ventures

Santen Ventures - Quick Facts

Who are Santen Ventures' competitors?

Companies similar to Santen Ventures include Takeda, Secure Ventures, Sorrento Ventures and P74 Ventures.

When was Santen Ventures founded?

Santen Ventures was founded in 2017.

Where is Santen Ventures' headquarters located?

Santen Ventures' headquarters is located in Emeryville, CA, US.

How much has Santen Ventures raised to-date?

As of Sep 1, 2011, Santen Ventures has raised a total of $59M (USD).

How many employees does Santen Ventures have?

Santen Ventures has 3,805 employees as of Feb 6, 2024.

Santen Ventures - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Revenue
  • Recurring
Main Product
  • Pharmaceuticals
Tags
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research